Overview
- 71 inspections across 70 sites are on record.
- 88 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-11-05.
At a glance
Inspections
71
Sites
70
Observations
88
Career since
Oct 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Daniel C. Tarquinio, DO | 5 Nov 2021 | Human Drugs | View 483 → |
| Jamie D. Weisman, MD | 24 Sep 2021 | Human Drugs | |
| Nathan Segall, MD, CPI | 13 Aug 2021 | Biologics | |
| Michael Dzimianski | 29 Jun 2021 | Animal Drugs & Feeds | |
| PPD, Inc., part of Thermo Fisher Scientific | 21 May 2021 | Medical Devices & Rad Health |
Sites inspected
Daniel C. Tarquinio, DONorcross, United States1 insp.
Jamie D. Weisman, MDSandy Springs, United States1 insp.
Nathan Segall, MD, CPIStockbridge, United States1 insp.
Michael DzimianskiAthens, United States1 insp.
PPD, Inc., part of Thermo Fisher ScientificMorrisville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Vanessa E Coulter9 shared
Lawrence Thomas2 shared
Sandra I Gaul1 shared
Nicole M Bell1 shared
Arlyss M Jones1 shared
Full investigator report
Get the verbatim findings behind Sereen G Morgan-Murray's 88 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site